Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    357336-20-0

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 7Briviact

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Briviact

    Brivaracetam

    arrow
    RDD
    Not Confirmed

    Brand Name : Briviact

    Belgium
    arrow
    RDD
    Not Confirmed

    UCB

    Brivaracetam

    Main Therapeutic Indication : CNS & Anesthesia

    Currency : USD

    2019 Revenue in Millions : 241

    2018 Revenue in Millions : 155

    Growth (%) : 56

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Briviact

    Brivaracetam

    arrow
    RDD
    Not Confirmed

    Brand Name : Briviact

    Belgium
    arrow
    RDD
    Not Confirmed

    UCB

    Brivaracetam

    Main Therapeutic Indication : CNS & Anesthesia

    Currency : USD

    2020 Revenue in Millions : 348

    2019 Revenue in Millions : 267

    Growth (%) : 30

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Briviact

    Brivaracetam

    arrow
    RDD
    Not Confirmed

    Brand Name : Briviact

    Belgium
    arrow
    RDD
    Not Confirmed

    UCB

    Brivaracetam

    Main Therapeutic Indication : Neurology

    Currency : USD

    2021 Revenue in Millions : 391

    2020 Revenue in Millions : 348

    Growth (%) : 23

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Briviact

    Brivaracetam

    arrow
    RDD
    Not Confirmed

    Brand Name : Briviact

    Belgium
    arrow
    RDD
    Not Confirmed

    UCB

    Brivaracetam

    Main Therapeutic Indication : Neurology

    Currency : USD

    2022 Revenue in Millions : 517

    2021 Revenue in Millions : 391

    Growth (%) : 32

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Briviact

    Brivaracetam

    arrow
    RDD
    Not Confirmed

    Brand Name : Briviact

    Belgium
    arrow
    RDD
    Not Confirmed

    UCB

    Brivaracetam

    Main Therapeutic Indication : Neurology

    Currency : USD

    2023 Revenue in Millions : 622

    2022 Revenue in Millions : 517

    Growth (%) : -16

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Briviact

    Brivaracetam

    arrow
    RDD
    Not Confirmed

    Brand Name : Briviact

    Belgium
    arrow
    RDD
    Not Confirmed

    UCB

    Brivaracetam

    Main Therapeutic Indication : Neurology

    Currency : USD

    2024 Revenue in Millions : 719

    2023 Revenue in Millions : 622

    Growth (%) : 16

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Briviact

    Brivaracetam

    arrow
    RDD
    Not Confirmed

    Brand Name : Briviact

    Belgium
    arrow
    RDD
    Not Confirmed

    UCB

    Brivaracetam

    Main Therapeutic Indication : Neurological/Mental Disorders

    Currency : USD

    2018 Revenue in Millions : 160

    2017 Revenue in Millions : 97

    Growth (%) : 65%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.